PER 2.00% 7.4¢ percheron therapeutics limited

Givinostat also has been tested in adults with Becker muscular...

  1. 4,336 Posts.
    lightbulb Created with Sketch. 2023
    Givinostat also has been tested in adults with Becker muscular dystrophy. Top-line results from a Phase 2 trial (NCT03238235) showed that treatment failed to reduce muscle scarring, a main trial goal, but its use stopped further muscle shrinkage and fat infiltration, suggesting it may slow or prevent disease progression.

    I wasnt correct in what I said about the adult trial.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.4¢
Change
-0.002(2.00%)
Mkt cap ! $66.26M
Open High Low Value Volume
7.5¢ 7.5¢ 7.1¢ $23.47K 321.4K

Buyers (Bids)

No. Vol. Price($)
4 29672 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.7¢ 50000 1
View Market Depth
Last trade - 12.34pm 30/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.